Literature DB >> 12484501

Proposition of a feasible protocol to evaluate salt sensitivity in a population-based setting.

Norihiro Kato1, Tomo Kanda, Miki Sagara, Angelo Bos, Emilio H Moriguchi, Yukio Moriguchi, Yukio Yamori.   

Abstract

Although a variety of techniques have been devised to assess salt sensitivity, most have proven cumbersome from a methodological perspective. We therefore attempted to develop a 2-week method by which participants could be tested in an outpatient setting without requirement of a strict dietary regimen. In this method, subjects take 140 mEq of an NaCl supplement per day for 1 week and 25 mg of hydrochlorothiazide daily for another week while maintaining their customary diet. In our first trial, 8 healthy volunteers submitted to this method, as well as to a widely-used rapid volume expansion and contraction protocol. Blood pressure measurements, blood sampling and 24-h urine collection were performed before, in the middle of, and after each intervention. There was a fair correlation (r = 0.69) between the two protocols with respect to the changes in mean blood pressure (deltaMBP), a measure of salt sensitivity. In our second trial, we tested the method on 82 Japanese subjects who had never been treated with antihypertensive drugs. DeltaMBP was significantly correlated with plasma renin activity (PRA) during salt loading (r = 0.52, p < 0.0001) and with the changes in atrial natriuretic peptide (deltaANP) (r = -0.34, p = 0.0018). When total subjects were divided into two subgroups by age, a similar tendency of correlation was observed. Age, PRA during salt loading, deltaANP, and delta norepinephrine were proven to be significant predictors of salt sensitivity and accounted for 46% of the deltaMBP variances. Based on these results, the dietary method presented here seems to be applicable for a population-based survey. Our preliminary data also suggest that PRA and ANP would be of predictive value in the salt sensitivity test.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12484501     DOI: 10.1291/hypres.25.801

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

Review 1.  Genetics of salt-sensitive hypertension.

Authors:  Hironobu Sanada; John E Jones; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

2.  Higher aldosterone and lower N-terminal proatrial natriuretic peptide as biomarkers of salt sensitivity in the community.

Authors:  Wolfgang Lieb; Michael J Pencina; Paul F Jacques; Thomas J Wang; Martin G Larson; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2011-02-11

3.  A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.

Authors:  John J Gildea; Dylan T Lahiff; Robert E Van Sciver; Ryan S Weiss; Neema Shah; Helen E McGrath; Cynthia D Schoeffel; Pedro A Jose; Robert M Carey; Robin A Felder
Journal:  Clin Chim Acta       Date:  2013-02-27       Impact factor: 3.786

Review 4.  Diagnostic tools for hypertension and salt sensitivity testing.

Authors:  Robin A Felder; Marquitta J White; Scott M Williams; Pedro A Jose
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-01       Impact factor: 2.894

5.  Characteristics of sodium sensitivity in Korean populations.

Authors:  Sung Joon Shin; Chi Yeon Lim; Moo-Yong Rhee; Sang Woo Oh; Sang Hoon Na; Yongsoon Park; Cho-Il Kim; Seo-Young Kim; Jong-Wook Kim; Hye-Kyung Park
Journal:  J Korean Med Sci       Date:  2011-07-27       Impact factor: 2.153

6.  Effects of elevation of ANP and its deficiency on cardiorenal function.

Authors:  Daria V Ilatovskaya; Vladislav Levchenko; Kristen Winsor; Gregory R Blass; Denisha R Spires; Elizaveta Sarsenova; Iuliia Polina; Adrian Zietara; Mark Paterson; Alison J Kriegel; Alexander Staruschenko
Journal:  JCI Insight       Date:  2022-05-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.